VIE/VTRS (VIE/VTRS)

Vienna Stock Exchange: VIE/VTRS · EUR

€16.9

+0.09 (+0.6%)· Recorded snapshot

Market cap	19.3B
Revenue (ttm)	12.9B
Net income (ttm)	-359.5M
EPS (ttm)	-€0.32
P/E (forward)	7.3x
Dividend	€0.41 (2.46%)

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 12.9B
Net income (ttm): -359.5M
EPS (ttm): -€0.32
P/E (forward): 7.3x
Market cap: 19.3B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/E7.3

P25 14.3P50 18.7P75 25.4

Trailing P/En/a

P25 20.4P50 26.7P75 39.7

ROE-2.8

P25 4.8P50 10.6P75 20.1

ROIC5.9

P25 5.8P50 9.5P75 18.2

Benchmarks · 1M

S&P 500+0.6%

Nasdaq Composite-2.3%

Dow Jones Industrial Average+1.9%

Russell 2000+1.8%

All VIE/VTRS indicators

Market & fundamental data

Available fields

219

Groups with data

Currency

USD

Showing 219 of 219 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	United States
Country code	AT
Earnings date	2026-11-05
Employees	30,000
Employees change	0
Employees growth	0%
Enterprise value	EUR 30.2B
Exchange	Vienna Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1961
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	No
ISIN number	US92556V1061
Last earnings date	2026-08-06
Last refreshed	2026-10-29
Market cap	EUR 19.3B
Next earnings date	2026-11-05
Price	EUR 16.85
Price currency	EUR
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	vie/VTRS
Website	https://www.viatris.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	84.86x
Earnings yield	-1.89%
EV/EBIT	21.48x
EV/EBITDA	7.68x
EV/FCF	17.66x
EV/Sales	2.28x
FCF / EV yield	5.66%
FCF yield	8.85%
Forward P/E	7.25x
P/(FCF - SBC) ratio	12.4x
P/(OCF - SBC) ratio	10.24x
P/B ratio	1.55x
P/FCF ratio	11.3x
P/OCF ratio	9.48x
P/S ratio	1.5x
Price/EBITDA ratio	5.15x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	10.64%
EBITDA margin	29.13%
FCF margin	12.93%
Gross margin	40.31%
Operating margin	10.64%
Pretax margin	-4.49%
Profit margin	-2.79%
Profit per employee	EUR -11,983
Revenue per employee	EUR 429,985
ROA	2.67%
ROA (5Y)	2.25%
ROCE	5.46%
ROE	-2.75%
ROE (5Y)	-3.98%
ROIC	5.89%
ROIC (5Y)	3.5%
SBC / revenue	1.17%
Tax / revenue	-1.71%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	0
FCF growth	11.61%
FCF growth (Q)	97.24%
FCF growth (QoQ)	-5.57%
FCF growth 3Y	-2.89%
FCF growth 5Y	3.13%
Gross profit growth	3.13%
Gross profit growth (Q)	9.93%
Gross profit growth 3Y	-4.17%
Gross profit growth 5Y	-1.04%
Net income growth years	0
OCF growth	12.9%
OCF growth (Q)	73.78%
OCF growth (QoQ)	-1.67%
OCF growth 10Y	0.93%
OCF growth 3Y	-2.41%
OCF growth 5Y	3.43%
Operating income growth	22.89%
Operating income growth (Q)	38.27%
Operating income growth 3Y	-12.23%
Operating income growth 5Y	4.24%
Revenue growth	4.4%
Revenue growth (Q)	4.88%
Revenue growth (QoQ)	6.82%
Revenue growth 10Y	4.02%
Revenue growth 3Y	-1.88%
Revenue growth 5Y	-1.14%
Revenue growth quarters	4
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -329.1M
Depreciation and amortization	EUR 2.4B
EBIT	EUR 1.4B
EBITDA	EUR 3.8B
EPS	EUR -0.32
Financing cash flow	EUR -1.7B
Free cash flow	EUR 1.7B
Free cash flow minus SBC	EUR 1.6B
Gross profit	EUR 5.2B
Income taxes	EUR -220.1M
Investing cash flow	EUR -73.8M
Net borrowing	EUR -829.4M
Net cash flow	EUR 282M
Net income	EUR -359.5M
Operating cash flow minus SBC	EUR 1.9B
Operating income	EUR 1.4B
Revenue	EUR 12.9B
Stock-based compensation	EUR 150.8M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	1.1
Book value per share	EUR 10.80
Debt / EBITDA	3.11
Debt / equity	0.96
Debt / FCF	6.97
Goodwill	EUR 6B
Interest coverage	3.27
Long-term assets	EUR 21.6B
Long-term liabilities	EUR 12.5B
Net cash (debt)	EUR -10.6B
Net cash / market cap	-54.81%
Net debt / EBITDA	2.82
Net debt / equity	0.85
Net debt / FCF	6.2
Piotroski F-Score	6
Property, plant and equipment	EUR 2.4B
Shareholders' equity	EUR 12.5B
Tangible book value	EUR -5.3B
Tangible book value per share	EUR -4.60
Total assets	EUR 30.7B
Total cash	EUR 1.3B
Total debt	EUR 11.9B
Total liabilities	EUR 18.2B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.4
Current assets	EUR 9B
Current liabilities	EUR 5.7B
Current ratio	1.58
Inventory turnover	2.15
Net working capital	EUR 3.5B
Quick ratio	0.82
Working capital	EUR 3.2B
Working capital turnover	4.06

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	2.45%
Dividend growth	-4.72%
Dividend growth (3Y)	-2.89%
Dividend growth years	0
Dividend payment date	2026-09-16
Dividend payment years	6
Dividend payout frequency	Quarterly
Dividend per share	EUR 0.41
Dividend yield	2.46%
Ex-dividend date	2026-08-21
Last dividend	EUR 0.10
Shareholder yield	4.9%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	EUR 14.21
1D price change	0.56%
1M price change	10.36%
1M total return	10.36%
1W price change	2.63%
1W total return	2.63%
1Y price change	89.43%
1Y return CAGR	96.19%
1Y total return	96.1%
20-day SMA	EUR 16.04
200-day SMA	EUR 13.70
3M price change	8.99%
3M total return	9.8%
3Y price change	100.43%
3Y return CAGR	31.48%
3Y total return	127.35%
50-day SMA	EUR 15.16
50-day SMA vs 200-day SMA	50over200
52-week high	EUR 16.92
52-week high date	2026-10-28
52-week low	EUR 8.68
52-week low date	2025-11-10
5Y price change	47.36%
5Y return CAGR	12.7%
5Y total return	81.76%
6M price change	33.83%
6M total return	35.82%
All-time high	EUR 16.92
All-time high date	2026-10-28
All-time low	EUR 6.26
All-time low date	2025-04-10
Average true range (ATR)	EUR 0.32
Average volume	0.3
Change from 52-week high	-0.43%
Change from 52-week low	94.19%
Change from all-time high	-0.43%
Change from all-time low	169.12%
Change from open	0.15%
Day's gap	0.41%
High price	EUR 16.92
Low price	EUR 16.80
Monthly RSI	69.6
Open price	EUR 16.83
Position in 52-week range	40.98%
Previous close	EUR 16.76
Price vs 150-day SMA	18.63%
Price vs 20-day SMA	5.04%
Price vs 200-day SMA	23.04%
Price vs 50-day SMA	11.17%
Relative volume	20
RSI	66.67
Sharpe ratio	2.26
Sharpe ratio (3Y)	0.83
Sharpe ratio (5Y)	0.4
Sortino ratio	4
Sortino ratio (3Y)	1.42
Sortino ratio (5Y)	0.76
Weekly RSI	70.73
YTD price change	60.5%
YTD total return	64.22%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1.1B
Shares change (QoQ)	-1.02%
Shares change (YoY)	-2.45%
Shares held by insiders	0.43%
Shares held by institutions	96.03%
Short ratio	4.1 days

Deeper analysis on VIE/VTRS

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Scorecard

Six-factor overlay and 9-category weighted scorecard.

→

Recommendation

Final action, action steps, opportunity, and biggest risk.

→

Perspectives

Growth, value, and income investor reads.

→

Frequently asked questions

About this VIE/VTRS report

Is a complete VIE/VTRS research report available?

No complete published report is available for vie/VTRS (VIE/VTRS) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Market cap

19.3B

Revenue (ttm)

12.9B

Net income (ttm)

-359.5M

EPS (ttm)

-€0.32

P/E (forward)

7.3x

Dividend

€0.41 (2.46%)

Metric

Value

Amount currency

EUR

Country

United States

Country code

Earnings date

2026-11-05

Employees

30,000

Employees change

Employees growth

Enterprise value

EUR 30.2B

Exchange

Vienna Stock Exchange

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-10

Fiscal year end

December

Founded

1961

Industry

Drug Manufacturers - Specialty & Generic

Is primary listing

ISIN number

US92556V1061

Last earnings date

2026-08-06

Last refreshed

2026-10-29

Market cap

EUR 19.3B

Next earnings date

2026-11-05

Price

EUR 16.85

Price currency

EUR

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

vie/VTRS

Website

https://www.viatris.com

Metric

Value

Average P/E ratio (10Y)

84.86x

Earnings yield

-1.89%

EV/EBIT

21.48x

EV/EBITDA

7.68x

EV/FCF

17.66x

EV/Sales

2.28x

FCF / EV yield

5.66%

FCF yield

8.85%

Forward P/E

7.25x

P/(FCF - SBC) ratio

12.4x

P/(OCF - SBC) ratio

10.24x

P/B ratio

1.55x

P/FCF ratio

11.3x

P/OCF ratio

9.48x

P/S ratio

1.5x

Price/EBITDA ratio

5.15x

Metric

Value

EBIT margin

10.64%

EBITDA margin

29.13%

FCF margin

12.93%

Gross margin

40.31%

Operating margin

10.64%

Pretax margin

-4.49%

Profit margin

-2.79%

Profit per employee

EUR -11,983

Revenue per employee

EUR 429,985

ROA

2.67%

ROA (5Y)

2.25%

ROCE

5.46%

ROE

-2.75%

ROE (5Y)

-3.98%

ROIC

5.89%

ROIC (5Y)

3.5%

SBC / revenue

1.17%

Tax / revenue

-1.71%

Metric

Value

EPS growth years

FCF growth

11.61%

FCF growth (Q)

97.24%

FCF growth (QoQ)

-5.57%

FCF growth 3Y

-2.89%

FCF growth 5Y

3.13%

Gross profit growth

3.13%

Gross profit growth (Q)

9.93%

Gross profit growth 3Y

-4.17%

Gross profit growth 5Y

-1.04%

Net income growth years

OCF growth

12.9%

OCF growth (Q)

73.78%

OCF growth (QoQ)

-1.67%

OCF growth 10Y

0.93%

OCF growth 3Y

-2.41%

OCF growth 5Y

3.43%

Operating income growth

22.89%

Operating income growth (Q)

38.27%

Operating income growth 3Y

-12.23%

Operating income growth 5Y

4.24%

Revenue growth

4.4%

Revenue growth (Q)

4.88%

Revenue growth (QoQ)

6.82%

Revenue growth 10Y

4.02%

Revenue growth 3Y

-1.88%

Revenue growth 5Y

-1.14%

Revenue growth quarters

Revenue growth years

Metric

Value

Capital expenditures

EUR -329.1M

Depreciation and amortization

EUR 2.4B

EBIT

EUR 1.4B

EBITDA

EUR 3.8B

EPS

EUR -0.32

Financing cash flow

EUR -1.7B

Free cash flow

EUR 1.7B

Free cash flow minus SBC

EUR 1.6B

Gross profit

EUR 5.2B

Income taxes

EUR -220.1M

Investing cash flow

EUR -73.8M

Net borrowing

EUR -829.4M

Net cash flow

EUR 282M

Net income

EUR -359.5M

Operating cash flow minus SBC

EUR 1.9B

Operating income

EUR 1.4B

Revenue

EUR 12.9B

Stock-based compensation

EUR 150.8M

Metric

Value

Altman Z-Score

1.1

Book value per share

EUR 10.80

Debt / EBITDA

3.11

Debt / equity

0.96

Debt / FCF

6.97

Goodwill

EUR 6B

Interest coverage

3.27

Long-term assets

EUR 21.6B

Long-term liabilities

EUR 12.5B

Net cash (debt)

EUR -10.6B

Net cash / market cap

-54.81%

Net debt / EBITDA

2.82

Net debt / equity

0.85

Net debt / FCF

6.2

Piotroski F-Score

Property, plant and equipment

EUR 2.4B

Shareholders' equity

EUR 12.5B

Tangible book value

EUR -5.3B

Tangible book value per share

EUR -4.60

Total assets

EUR 30.7B

Total cash

EUR 1.3B

Total debt

EUR 11.9B

Total liabilities

EUR 18.2B

Metric

Value

Asset turnover

0.4

Current assets

EUR 9B

Current liabilities

EUR 5.7B

Current ratio

1.58

Inventory turnover

2.15

Net working capital

EUR 3.5B

Quick ratio

0.82

Working capital

EUR 3.2B

Working capital turnover

4.06

Metric

Value

Buyback yield / dilution

2.45%

Dividend growth

-4.72%

Dividend growth (3Y)

-2.89%

Dividend growth years

Dividend payment date

2026-09-16

Dividend payment years

Dividend payout frequency

Quarterly

Dividend per share

EUR 0.41

Dividend yield

2.46%

Ex-dividend date

2026-08-21

Last dividend

EUR 0.10

Shareholder yield

4.9%

Metric

Value

150-day SMA

EUR 14.21

1D price change

0.56%

1M price change

10.36%

1M total return

10.36%

1W price change

2.63%

1W total return

2.63%

1Y price change

89.43%

1Y return CAGR

96.19%

1Y total return

96.1%

20-day SMA

EUR 16.04

200-day SMA

EUR 13.70

3M price change

8.99%

3M total return

9.8%

3Y price change

100.43%

3Y return CAGR

31.48%

3Y total return

127.35%

50-day SMA

EUR 15.16

50-day SMA vs 200-day SMA

50over200

52-week high

EUR 16.92

52-week high date

2026-10-28

52-week low

EUR 8.68

52-week low date

2025-11-10

5Y price change

47.36%

5Y return CAGR

12.7%

5Y total return

81.76%

6M price change

33.83%

6M total return

35.82%

All-time high

EUR 16.92

All-time high date

2026-10-28

All-time low

EUR 6.26

All-time low date

2025-04-10

Average true range (ATR)

EUR 0.32

Average volume

0.3

Change from 52-week high

-0.43%

Change from 52-week low

94.19%

Change from all-time high

-0.43%

Change from all-time low

169.12%

Change from open

0.15%

Day's gap

0.41%

High price

EUR 16.92

Low price

EUR 16.80

Monthly RSI

69.6

Open price

EUR 16.83

Position in 52-week range

40.98%

Previous close

EUR 16.76

Price vs 150-day SMA

18.63%

Price vs 20-day SMA

5.04%

Price vs 200-day SMA

23.04%

Price vs 50-day SMA

11.17%

Relative volume

RSI

66.67

Sharpe ratio

2.26

Sharpe ratio (3Y)

0.83

Sharpe ratio (5Y)

0.4

Sortino ratio

Sortino ratio (3Y)

1.42

Sortino ratio (5Y)

0.76

Weekly RSI

70.73

YTD price change

60.5%

YTD total return

64.22%

Metric

Value

Float

1.1B

Shares change (QoQ)

-1.02%

Shares change (YoY)

-2.45%

Shares held by insiders

0.43%

Shares held by institutions

96.03%

Short ratio

4.1 days

VIE/VTRS (VIE/VTRS)

Price

Financial snapshot

Fair-value bridge

Latest news · VIE/VTRS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All VIE/VTRS indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on VIE/VTRS

Frequently asked questions

VIE/VTRS (VIE/VTRS)

Price

Financial snapshot

Fair-value bridge

Latest news · VIE/VTRS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All VIE/VTRS indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on VIE/VTRS

Frequently asked questions